No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr20:23637200-23660000 |
Weak transcription |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
2 |
chr20:23659800-23660400 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
3 |
chr20:23659800-23660600 |
Enhancers |
HMEC |
breast
|
4 |
chr20:23660000-23660600 |
Enhancers |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
5 |
chr20:23660000-23661200 |
Enhancers |
Right Atrium |
heart
|
6 |
chr20:23660200-23660600 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
7 |
chr20:23660400-23661000 |
Enhancers |
Adipose Nuclei |
Adipose
|
8 |
chr20:23660400-23661200 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
9 |
chr20:23660400-23661200 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
10 |
chr20:23660400-23661200 |
Enhancers |
Left Ventricle |
heart
|
11 |
chr20:23660400-23661200 |
Enhancers |
Monocytes-CD14+_RO01746 |
blood
|
12 |
chr20:23660600-23661200 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
13 |
chr20:23660600-23661200 |
Enhancers |
Lung |
lung
|
14 |
chr20:23660600-23661200 |
Enhancers |
Skeletal Muscle Female |
skeletal muscle
|
15 |
chr20:23660600-23668600 |
Weak transcription |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
16 |
chr20:23660800-23661200 |
Enhancers |
Ovary |
ovary
|
17 |
chr20:23660800-23662000 |
Enhancers |
Brain Germinal Matrix |
brain
|
18 |
chr20:23662400-23662800 |
Enhancers |
NHLF |
lung
|
19 |
chr20:23662800-23663200 |
Weak transcription |
NHLF |
lung
|
20 |
chr20:23662800-23664200 |
Enhancers |
NHDF-Ad |
bronchial
|
21 |
chr20:23662800-23665200 |
Enhancers |
HUVEC |
blood vessel
|
22 |
chr20:23663200-23663800 |
Enhancers |
NHLF |
lung
|
23 |
chr20:23663400-23664400 |
Enhancers |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
24 |
chr20:23663600-23665000 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
25 |
chr20:23663800-23672400 |
Weak transcription |
NHLF |
lung
|
26 |
chr20:23664800-23665000 |
Enhancers |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
27 |
chr20:23665000-23666000 |
Weak transcription |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
28 |
chr20:23665200-23669000 |
Weak transcription |
HUVEC |
blood vessel
|
29 |
chr20:23665800-23666400 |
Enhancers |
Cortex derived primary cultured neurospheres |
brain
|
30 |
chr20:23666000-23666400 |
Enhancers |
Ganglion Eminence derived primary cultured neurospheres |
brain
|
31 |
chr20:23666000-23667000 |
Enhancers |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
32 |
chr20:23667000-23672200 |
Weak transcription |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
33 |
chr20:23667200-23667400 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
34 |
chr20:23667400-23668800 |
Weak transcription |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
35 |
chr20:23668600-23670000 |
Enhancers |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
36 |
chr20:23668800-23669000 |
Bivalent Enhancer |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
37 |
chr20:23668800-23669000 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
38 |
chr20:23668800-23669000 |
Enhancers |
Spleen |
Spleen
|
39 |
chr20:23669000-23669200 |
Bivalent Enhancer |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
40 |
chr20:23669000-23669800 |
Weak transcription |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
41 |
chr20:23669000-23671000 |
Enhancers |
HUVEC |
blood vessel
|
42 |
chr20:23669200-23670200 |
Enhancers |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
43 |
chr20:23669800-23670000 |
Enhancers |
Lung |
lung
|
44 |
chr20:23669800-23670400 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
45 |
chr20:23670000-23672000 |
Weak transcription |
Lung |
lung
|
46 |
chr20:23670200-23671200 |
Weak transcription |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
47 |
chr20:23670400-23671400 |
Weak transcription |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
48 |
chr20:23670800-23671000 |
Bivalent Enhancer |
Placenta |
Placenta
|
49 |
chr20:23670800-23673600 |
Weak transcription |
Spleen |
Spleen
|
50 |
chr20:23671000-23672000 |
Weak transcription |
HUVEC |
blood vessel
|